Gini Deshpande
Fondatore presso NuMedii, Inc.
Posizioni attive di Gini Deshpande
Società | Posizione | Inizio | Fine |
---|---|---|---|
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Direttore/Membro del Consiglio | 01/01/2008 | - |
Amministratore Delegato | 01/01/2008 | - | |
Fondatore | 01/01/2008 | - | |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Investitore di Private Equity | 01/01/2021 | - |
Storia della carriera di Gini Deshpande
Formazione di Gini Deshpande
Purdue University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Francia | 2 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Commercial Services | 2 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Commercial Services |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Finance |
- Borsa valori
- Insiders
- Gini Deshpande
- Esperienza